HPLC and Mass Spectrometry: How Peptide Purity Is Verified

August 6, 2026 ·4 min read · Last reviewed August 28, 2026

“99% purity” appears on almost every peptide listing on the internet. The number is meaningless without knowing how it was produced. This article covers the two analytical techniques behind a credible purity claim, what each one can and cannot tell you, and why both are needed.

The problem being solved

Solid-phase peptide synthesis builds a chain one residue at a time. Each coupling step is efficient but not perfect. Over a 30-residue sequence, small per-step failures accumulate into a product mixture containing the target sequence plus a family of closely related by-products — chains missing a residue, chains with incomplete deprotection, oxidised variants.

Purification removes most of this. Analysis is how you find out how much was removed, and what remains.

HPLC: how much

High-performance liquid chromatography pushes a dissolved sample through a packed column under pressure. Components travel at different speeds depending on how strongly they interact with the column material, so they emerge separated in time. A detector at the outlet records what passes, producing a chromatogram.

For peptides, reversed-phase HPLC is standard: a nonpolar column with a water/acetonitrile gradient, separating primarily by hydrophobicity. Detection is usually UV absorbance around 214 nm, where the peptide bond itself absorbs.

Purity is reported as the area of the main peak divided by the total area of all peaks. Reading it properly means looking past the headline figure:

• Resolution. Two compounds that co-elute appear as one peak. A deletion sequence differing by a single residue can be very difficult to separate, and if it is not resolved, it is counted as product.
• Detection wavelength. UV at 214 nm detects the peptide backbone, so it sees most peptidic impurities. Non-peptidic contaminants such as residual salts absorb weakly or not at all and are invisible to the method.
• Gradient length. A short, steep gradient runs quickly but resolves poorly. A shallow gradient separates more.

The critical limitation: HPLC does not identify anything. It reports that one component dominates the mixture. It cannot tell you that component is the peptide you ordered.

Mass spectrometry: which molecule

Mass spectrometry ionises the sample and measures mass-to-charge ratio, giving molecular mass directly. For peptide work, electrospray ionisation (ESI-MS) and MALDI-TOF are the usual methods.

The check is straightforward: calculate the theoretical monoisotopic or average mass from the sequence, and compare it with the observed mass. Agreement within the instrument’s accuracy confirms identity.

Common discrepancies are informative rather than random:

• −18 Da — loss of water, often cyclisation or dehydration.
• +16 Da — addition of one oxygen, typically oxidation of methionine.
• +1 Da — deamidation of asparagine or glutamine.
• A residue-sized gap — a deletion sequence, where one amino acid failed to couple.

Mass spectrometry has its own blind spot: it measures mass, not sequence order. Two peptides with the same amino acid composition in a different order have identical mass. Distinguishing them requires tandem MS (MS/MS), which fragments the molecule and reads the sequence from the fragment pattern.

Why both, together

The two techniques answer different questions and neither is sufficient alone:

• HPLC alone: “one component dominates” — but which?
• MS alone: “the target compound is present” — but at what proportion?
• Together: “the dominant component is the target compound, at this purity.”

A supplier reporting only a purity percentage, with no mass confirmation, has given you half the picture. In practice the analyses are often coupled directly as LC-MS, so each separated peak can be mass-identified as it elutes.

Beyond purity and identity

For work involving cell culture, two further tests matter:

Endotoxin testing detects bacterial lipopolysaccharide, which can trigger strong biological responses at extremely low concentrations and confound results in ways that look like a real effect.

Peptide content analysis quantifies how much of the lyophilised mass is actually peptide, as distinct from residual water and counter-ions such as trifluoroacetate or acetate. A vial labelled 5 mg refers to gross lyophilisate mass unless stated otherwise; net peptide content is typically lower. For quantitative work this distinction is not academic.

What to ask a supplier

Three questions separate documented material from a claim:

1. Which laboratory performed the analysis, and is it independent of the seller?
2. Does the report cover both HPLC purity and mass-spectrometric identity?
3. Does the batch number on the report match the batch number on my vial?

Every batch we supply is analysed by Janoshik Analytical, an independent third-party laboratory, covering HPLC purity, mass-spectrometric identity, endotoxins and heavy metals. Batch-matched certificates are available on request — details in our FAQ, or browse the catalog.

All products and information referenced are for in-vitro research and laboratory use only. Nothing here is medical advice, and no therapeutic claim is made or implied.